Multicompartment metabolism in papillary thyroid cancer

Laryngoscope

Volumn 126, Issue 10, 2016, Pages 2410-2418

  Curry, Joseph M ^a   Tassone, Patrick ^a   Cotzia, Paolo ^a   Sprandio, John ^a   Luginbuhl, Adam ^a   Cognetti, David M ^a   Mollaee, Mehri ^a   Domingo Vidal, Marina ^a   Pribitkin, Edmund A ^a   Keane, William M ^a   Zhan, Tingting ^a   Birbe, Ruth ^a   Tuluc, Madalina ^a   Martinez Outschoorn, Ubaldo ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

cancer; coupling; metabolism; papillary; thyroid

Indexed keywords

MONOCARBOXYLATE TRANSPORTER 4; TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 20;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROBLAST; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; MALE; METASTASIS; NODULAR GOITER; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR CELL; THYROID GLAND TISSUE; THYROIDECTOMY;

EID: 84990177797     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.25799     Document Type: Article

References (39)

1. Martinez-Outschoorn UE, Lin Z, Trimmer C, et al. Cancer cells metabolically “fertilize” the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011;10:2504–2520.
2. Curry JM, Tuluc M, Whitaker-Menezes D, et al. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle 2013;12:1371–1384.
3. Martinez-Outschoorn UE, Curry JM, Ko YH, et al. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkappaB target stromal MCT4. Cell Cycle 2013;12:2580–2597.
4. Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 2009;92:329–333.
5. Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power surge: supporting cells “fuel” cancer cell mitochondria. Cell Metab 2012;15:4–5.
6. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, et al. Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010;9:3506–3514.
7. Martinez-Outschoorn UE, Goldberg A, Lin Z, et al. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biol Ther 2011;12:924–938.
8. Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol 2014;25C:47–60.
9. Witkiewicz AK, Whitaker-Menezes D, Dasgupta A, et al. Using the “reverse Warburg effect” to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle 2012;11:1108–1117.
10. Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 2000;19:2060–2066.
11. Nilubol N, Sukchotrat C, Zhang L, He M, Kebebew E. Molecular pathways associated with mortality in papillary thyroid cancer. Surgery 2011;150:1023–1031.
12. Fagin JA. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J Endocrinol 2004;183:249–256.
13. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292–306.
14. Fagin JA, Mitsiades N. Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 2008;22:955–969.
15. Weinberg F, Hamanaka R, Wheaton WW, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 2010;107:8788–8793.
16. Ramanathan A, Wang C, Schreiber SL. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A 2005;102:5992–5997.
17. Migneco G, Whitaker-Menezes D, Chiavarina B, et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010;9:2412–2422.
18. Wurm CA, Neumann D, Lauterbach MA, et al. Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an inner-cellular gradient. Proc Natl Acad Sci U S A 2011;108:13546–13551.
19. Gehrke S, Wu Z, Klinkenberg M, et al. PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane. Cell Metab 2015;21:95–108.
20. Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006;281:9030–9037.
21. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–1214.
22. Gallagher SM, Castorino JJ, Wang D, Philp NJ. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 2007;67:4182–4189.
23. R Core Team. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2015. Available at: http://www.R-project.org/.
24. Zamar D MBaGJ. elrm: Software implementing exact-like inference for logistic regression models. J Stat Softw 2007;21. Accessed September 22, 2015.
25. Martinez-Outschoorn U, Sotgia F, Lisanti MP. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Semin Oncol 2014;41:195–216.
26. Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer 2011;11:167.
27. Semenza GL. Tumor metabolism: cancer cells give and take lactate. J Clin Invest 2008;118:3835–3837.
28. Curry JM, Sprandio J, Cognetti D, et al. Tumor microenvironment in head and neck squamous cell carcinoma. Semin Oncol 2014;41:217–234.
29. Wallace DC. Mitochondria and cancer. Nat Rev Cancer 2012;12:685–698.
30. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029–1033.
31. Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011;17:1498–1503.
32. Obre E, Rossignol R. Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. Int J Biochem Cell Biol 2015;59C:167–181.
33. Fidler IJ, Poste G. The “seed and soil” hypothesis revisited. Lancet Oncol 2008;9:808.
34. Fiaschi T, Marini A, Giannoni E, et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 2012;72:5130–5140.
35. Martinez-Outschoorn UE, Whitaker-Menezes D, Valsecchi M, et al. Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome? Semin Oncol 2013;40:403–418.
36. Kim MH, Ko SH, Bae JS, et al. Non-FDG-avid primary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma. Thyroid 2013;23:1452–1460.
37. Klubo-Gwiezdzinska J, Costello J, Jr., Patel A, et al. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab 2013;98:3269–3279.
38. Cho SW, Yi KH, Han SK, et al. Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo. Mol Cell Endocrinol 2014;393:24–29.
39. Shih SR, Chiu WY, Chang TC, Tseng CH. Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res 2012;2012:578285.